Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cyclometalated ruthenium complex, and preparation method and application thereof

A technology of cyclometalation and ruthenium complexes, which is applied in the field of DNA insertion reagents and anticancer drugs, to achieve the effects of high-efficiency anticancer drugs, overcoming the defects of tumor treatment, and strong growth inhibition ability

Inactive Publication Date: 2014-01-15
SUN YAT SEN UNIV
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the series of metal ruthenium complexes, two have entered the stage of clinical trials: NAMI-A was first synthesized by Alessio et al. in 1994. They found that although these complexes were not active in vitro, they were effective against mice. metastases have a significant inhibitory effect on

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cyclometalated ruthenium complex, and preparation method and application thereof
  • Cyclometalated ruthenium complex, and preparation method and application thereof
  • Cyclometalated ruthenium complex, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] The preparation method of embodiment 1 ligand and complex

[0043] (1) Synthetic method of ligand dppz:

[0044] a) Synthesis method of 1,10-phenanthrolene-5,6-dione:

[0045] The synthesis of 1,10-phenanthroline-5,6-dione is according to (J.Am.Chem.Soc.1993,115,3448) method: stir 4.0g phenanthroline and 4.0g potassium bromide And placed in a 250mL round bottom flask, then dropwise added cold concentrated sulfuric acid (40mL) and concentrated nitric acid (20mL) mixed acid. After the dropwise addition, heat and reflux at 100°C for 3h, cool to room temperature, pour it into 500mL ice water, and then use 10molL -1 The NaOH solution was carefully neutralized to neutral, and the solution was extracted with 3×100 mL of chloroform. After combining the organic phases, they were washed with 50 mL of water, and finally dried overnight with anhydrous sodium sulfate. Filtrate, remove chloroform under reduced pressure, recrystallize the solid product from ethanol to obtain orange...

Embodiment 2

[0056] The ultraviolet-visible spectroscopic titration experiment of embodiment 2 complex

[0057] When the transition metal complex interacts with DNA, the absorption spectrum wavelength and absorption intensity change due to the change of the environment in which the complex resides, and the wavelength and absorption intensity change in different ways when the complex interacts with DNA. When small molecules are DNA-bonded in an intercalation manner, the corresponding absorption peaks produce obvious hypochromicity, accompanied by a certain degree of red shift (red shift). This is due to the π-electron stacking between the insertion ligand and the base pair of DNA, making it π * After the empty orbital is coupled with the p-electron orbital of the base pair, the energy level decreases, resulting in π→π * The transition energy decreases, resulting in a redshift. Simultaneously coupled π * Empty orbitals are partially filled with electrons, making π→π * The transition chan...

Embodiment 3

[0058] Transcription inhibition experiment of the complex of embodiment 3

[0059] Complexes with large planar ligands can be inserted into the double strands of DNA, preventing T7 RNA polymerase from binding to template DNA during DNA transcription, thus effectively preventing DNA transcription. In transcription inhibition experiments, varying the content of the complex and keeping the other components constant, the final content of RNA produced was used as a measure of repressive capacity. Depend on Figure 5 As can be seen from the figure below, the IC of the transcriptional inhibition ability of the complex 50 The value is 7.5 μM.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention aims at developing a novel DNA (deoxyribonucleic acid) inserting reagent with good antitumor activity. A cyclometalated single-core ruthenium (II) complex is synthetized. The complex is stable in structure; the water-solubility is better than that of a common organic small molecular reagent at present; good DNA transcription inhibitory activity is represented. A cytotoxicity test indicates that the cyclometalated ruthenium (II) complex has significant growth inhibition effects on cancer cells of 11 different tissue parts of a human body; the inhibitory activity is much better than that of cis-platinum.

Description

technical field [0001] The invention relates to the fields of DNA insertion reagents and anticancer drugs, in particular to a preparation method and application of a novel cyclometalated ruthenium polypyridine complex. Background technique [0002] About 7.6 million people die of cancer every year in the world, accounting for 13% of the total death toll. Every year, 12.7 million cancer patients are diagnosed worldwide. In my country, about 1.5 million people die of cancer every year, and the trend is gradually increasing every year. Tumor treatment mainly includes three aspects: surgery, radiation therapy and chemotherapy. Chemotherapy is the method of treating diseases with chemically synthesized drugs. Chemotherapy is currently one of the main means of treating tumors and some autoimmune diseases. Chemotherapy refers to the application of drugs to treat cancer. These special drugs can kill tumor cells. There are currently more than 50 chemotherapy drugs. These anti-tumor ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07F15/00A61P35/00
Inventor 巢晖黄怀义张平玉计亮年
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com